Research Reports

Summary

CareDx, Inc. announced on April 20, 2026 that the Compensation and Human Capital Committee approved equity awards for Keith Kennedy in connection with his February 26, 2026 appointment as both Chief Financial Officer and Chief Operating Officer, while his base salary and target bonus remained unchanged.

Key takeaways

Keith Kennedy was appointed Chief Financial Officer and Chief Operating Officer effective February 26, 2026 — consolidating two critical executive roles under one leader.

On April 20, 2026, the Compensation and Human Capital Committee awarded 24,134 time-based RSUs with graded quarterly vesting beginning April 6, 2027 — formalizing compensation for expanded responsibilities.

The Committee also awarded 24,134 performance-based RSUs (PRSUs) tied to 2026–2027 performance periods, with potential payout between 0% and 200% of target — introducing variable, results-linked equity compensation.

Kennedy’s annual base salary remains $613,000 and target bonus opportunity remains 75% of base salary — no changes to cash compensation were made.

Full analysis

The appointment of Keith Kennedy to dual roles as Chief Financial Officer and Chief Operating Officer reflects a strategic consolidation of leadership responsibilities at CareDx, signaling operational and financial integration priorities. His prior service as COO provided continuity, but the addition of CFO duties introduces heightened accountability for financial reporting, capital allocation, and investor communications. The April 20, 2026 equity awards—comprising equal grants of time-based RSUs and performance-based RSUs—explicitly link compensation to both tenure and measurable corporate objectives across two fiscal years. The PRSUs’ 0%–200% payout range underscores management’s emphasis on disciplined execution against near-term financial and operational milestones. Notably, no adjustment was made to Kennedy’s cash compensation, suggesting the equity grants are intended to fully recognize the scope expansion without altering fixed cost structure. This move may reduce near-term succession risk but concentrates decision-making authority, warranting investor attention to delegation practices and internal controls over financial reporting.